Patent ID: 9220759
Filing Date: 2015-12-29
Classification: A61F,A61K,A61P

Abstract:
1. A method of treating, preventing, or ameliorating a vascular disease in a diabetic patient, the method comprising: implanting a stent comprising a first drug in a vascular region of a diabetic patient; and administering a second drug to the diabetic patient via transdermal administration; wherein the first drug is an anti-inflammatory, an antiproliferative, an antineoplastic, an antimitotic, an antiplatelet, an anticoagulant, an antifibrin, an antithrombin, an antibiotic, an anti-allergic, an antioxidant substance, or any combination thereof; and wherein the second drug reduces platelet activation, reduces tissue factor activity, reduces thrombin activity, or any combination thereof.